ProQR Therapeutics
PRQR
PRQR
34 hedge funds and large institutions have $378M invested in ProQR Therapeutics in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
Holders
34
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$72.4M | |
| 2 | +$28.1M | |
| 3 | +$25.1M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$14.7M |
| 5 |
O
OrbiMed
New York
|
+$14.2M |
Top Sellers
| 1 | -$4.15M | |
| 2 | -$3.87M | |
| 3 | -$1.84M | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$1.62M |
| 5 |
Millennium Management
New York
|
-$1.43M |